Connection

Aldo Maggioni to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Aged, 80 and over.
Aldo Maggioni
Connection Strength
0.169
Aged, 80 and over
  1. Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: Data from a large database in a community setting. Eur J Prev Cardiol. 2019 05; 26(8):836-846.
    View in: PubMed
    Score: 0.022
  2. The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):527-535.
    View in: PubMed
    Score: 0.022
  3. Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients. J Cardiovasc Comput Tomogr. 2021 Sep-Oct; 15(5):421-430.
    View in: PubMed
    Score: 0.007
  4. Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients. Drugs Aging. 2021 04; 38(4):341-346.
    View in: PubMed
    Score: 0.006
  5. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933.
    View in: PubMed
    Score: 0.006
  6. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 10 14; 40(39):3222-3232.
    View in: PubMed
    Score: 0.006
  7. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019 10; 140(14):1156-1169.
    View in: PubMed
    Score: 0.006
  8. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 10; 7(10):862-874.
    View in: PubMed
    Score: 0.006
  9. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. Europace. 2019 07 01; 21(7):1013-1022.
    View in: PubMed
    Score: 0.006
  10. Stroke Outcomes in the COMPASS Trial. Circulation. 2019 02 26; 139(9):1134-1145.
    View in: PubMed
    Score: 0.006
  11. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study. Europace. 2019 Feb 01; 21(2):230-238.
    View in: PubMed
    Score: 0.006
  12. Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation. Eur J Prev Cardiol. 2019 04; 26(6):660-663.
    View in: PubMed
    Score: 0.005
  13. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. Int J Cardiol. 2018 Nov 15; 271:68-74.
    View in: PubMed
    Score: 0.005
  14. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. Eur Heart J Cardiovasc Pharmacother. 2018 07 01; 4(3):172-179.
    View in: PubMed
    Score: 0.005
  15. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 07; 11(7):e004962.
    View in: PubMed
    Score: 0.005
  16. Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran. Cardiovasc Drugs Ther. 2018 06; 32(3):281-286.
    View in: PubMed
    Score: 0.005
  17. Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure. Int J Cardiol. 2018 Aug 15; 265:162-168.
    View in: PubMed
    Score: 0.005
  18. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Atherosclerosis. 2018 04; 271:120-127.
    View in: PubMed
    Score: 0.005
  19. East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort. Eur J Heart Fail. 2018 06; 20(6):1071-1075.
    View in: PubMed
    Score: 0.005
  20. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2018 Mar; 107(3):214-221.
    View in: PubMed
    Score: 0.005
  21. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 02; 20(2):345-354.
    View in: PubMed
    Score: 0.005
  22. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017 Aug 24; 3:17058.
    View in: PubMed
    Score: 0.005
  23. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. J Am Heart Assoc. 2017 Jul 05; 6(7).
    View in: PubMed
    Score: 0.005
  24. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964.
    View in: PubMed
    Score: 0.005
  25. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]. G Ital Cardiol (Rome). 2007 Feb; 8(2):102-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.